M. Parsons

Johnson & Johnson (United States)

Papers

1

Total Citations

1

H-Index

1

About

M. Parsons is a leading figure in interventional pulmonology, with a primary research focus on advancing the diagnostic accuracy and procedural safety of bronchoscopic techniques for lung cancer detection. Their most notable contribution is the development and multicenter validation of a novel biopsy assessment system for the intraprocedural evaluation of lung biopsies obtained via robotic-assisted bronchoscopy. This landmark study, published in 2023, introduced a standardized, real-time tissue assessment protocol that significantly improves the immediate yield of peripheral lung nodule sampling, reducing the need for repeat procedures. While still early in its citation history, this work represents a paradigm shift in how robotic bronchoscopy is performed, moving from blind sampling to informed, quality-controlled tissue acquisition. Parsons’ research sits at the intersection of device innovation, clinical workflow optimization, and patient-centered outcomes, directly addressing the critical challenge of diagnosing small, hard-to-reach lung lesions. Their ongoing work continues to shape the next generation of minimally invasive lung cancer diagnostics, with implications for earlier detection and reduced procedural morbidity.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter Prospective Study of Novel Biopsy Assessment System for the Intraprocedural Evaluation of Lung Biopsies by Robotic Assisted Bronchoscopy
1 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago